Article
Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.
Frontiers in immunology - 1 Jan 2024
Zhang Yi, Wang Yuzhi, Qian Haitao
Abstract excerpt
Background: Lung adenocarcinoma (LUAD) is a heterogeneous tumor characterized by diverse genetic and molecular alterations. Developing a multi-omics-based classification system for LUAD is urgently needed to advance biological understanding. Methods: Data on clinical and pathological characteristics, genetic alterations, DNA methylation patterns, and the expression of mRNA, lncRNA, and microRNA, along with...
Topics
- Humans
- Adenocarcinoma of Lung
- Machine Learning
- Lung Neoplasms
- Immunotherapy
- Biomarkers, Tumor
- Gene Expression Regulation, Neoplastic
- Prognosis
- Mutation
- Computational Biology
- Gene Expression Profiling
